Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Trudeau found in contempt of court

This article was originally published in The Tan Sheet

Executive Summary

The U.S. District Court for the Northern District of Illinois finds Kevin Trudeau in contempt for violating a 2004 permanent injunction by misrepresenting the contents of his book "The Weight Loss Cure 'They' Don't Want You to Know About," in infomercials, the Federal Trade Commission announces Nov. 21. The permanent injunction had prohibited Trudeau from misrepresenting the content of books, in addition to banning him from using infomercials to sell any products. The court ruled Trudeau "misled thousands of consumers" with a diet protocol he touted as "easy," but actually involved extreme dieting, daily injections and lifelong dietary restrictions. FTC filed a brief in September asking the court to find Trudeau in contempt (1"The Tan Sheet" Sept. 17, 2007, In Brief)...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101165

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel